Cequent Pharmaceuticals' Other Investors

Cequent Pharmaceuticals raised a round of funding on , . Investors include Beth Israel Deaconess Medical Center.

Cequent is an early-stage biopharmaceutical company developing new clinically compatible therapies based on RNA interference (RNAi). Cequent is focusing its efforts on the pre-clinical development of …

Articles about Cequent Pharmaceuticals' Other Investors: